Is marijuana bad for the brain? Not at all: according to a study by Tel Aviv University, published in the journal Behavioral Brain Research and Experimental Brain Research, extremely low doses of this substance could protect the brain before and after an injury.
Don't store avocado like this: it's dangerous
Is marijuana bad for the brain? Not at all: according to a study by Tel Aviv University, published in the magazine Behavioural Brain Research and Experimental Brain Research, extremely low doses of this substance could protect the brain before and after an injury.
The merit, in particular, would be of the active ingredient of marijuana, the Thc, which it would be able to prevent long-term cognitive impairment as a result of injury from hypoxia, seizures or even damage caused by toxic drugs when given in small doses. Without this protective barrier, however, brains are prone to cognitive defects and neurological damage. But how did they find out? To test their theory, Tel Aviv University Professor Yosef Sarne and his team injected very low doses of THC into lab mice, both before and after subjecting them to brain trauma.
This is how he was able to establish that small doses of THC can be given up to seven days before an injury or three days after. Just three days before I did any harm to the mice, and 7 days later, researchers ran tests for brain damage. Those who received a low dose did much better than the control group of mice that received no treatment. And the THC group of mice did even more neuroprotective chemicals in their system, revealing, the researchers say, that this treatment acts almost like an immunization of brain damage.
Right in the middle of the antivivisectionist debate, with the researchers ready to take to the streets to reaffirm the validity of their methods, this research is yet another opportunity to be seized in order to remember how no species can be taken as a model for another. “Animal testing is a useless and harmful method. 90% of medicines tested on animals are rejected before clinical trials in humans, because the tests are considered unreliable. But it is obvious: each animal species has its own unique and unrepeatable genome ", explains in an interview Claude Reiss, research director in molecular biology at CNRS for 35 years, author of hundreds of scientific papers on the subject.
This means that a rat, a mouse, a dog or a man react completely differently to the same test. In short, it would have been much more useful and profitable to carry out these experiments on a human model. But causing trauma to a man's brain to study the effect of THC would not be "ethical" ...
Roberta Ragni
